Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (stic) in the sectioning and extensively examining the fimbriated end (see-fim) protocol?

International Journal of Gynecological Pathology

Volumn 32, Issue 4, 2013, Pages 353-357

  Mahe, Etienne ^a   Tang, Shangguo ^a,b   Deb, Pratima ^a,b   Sur, Monalisa ^b,c   Lytwyn, Alice ^b,c   Daya, Dean ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Deeper sections; Fallopian tube neoplasms; Neoadjuvant chemotherapy; Serous carcinoma; Serous tubal intraepithelial carcinoma; Step sections

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; OVARY SEROUS CARCINOMA; PRIORITY JOURNAL; SALPINGECTOMY; SEROUS TUBAL INTRAEPITHELAIL CARCINOMA; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE TUBE CARCINOMA; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; OVARY TUMOR; PATHOLOGY; PELVIC NEOPLASMS; PERITONEUM TUMOR; RISK; UTERINE TUBE;

CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PERITONEAL NEOPLASMS; RISK; SALPINGECTOMY;

EID: 84880240466     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318264ae09     Document Type: Article

References (26)

1. Kurman RJ, Shih I. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol 2010;34:433-43.
2. Folkins AK, Jarboe EA, Roh MH, et al. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 2009;113:391-6.
3. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-6. (Pubitemid 43740193)
4. Piek JM, Kenemans P, Verheijen RH. Intraperitoneal serous adenocarcinoma: A critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol 2004;191:718-32. (Pubitemid 39298100)
5. Jarboe EA, Pizer ES, Miron A, et al. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod Pathol 2009;22:345-50.
6. Jarboe EA, Miron A, Carlson JW, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: Frequency and potential significance. Int J Gynecol Pathol 2009;28:308-15.
7. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007;31:161-9. (Pubitemid 46175016)
8. Carlson JW, Jarboe EA, Kindelberger D, et al. Serous tubal intraepithelial carcinoma: Diagnostic reproducibility and its implications. Int J Gynecol Pathol 2010;29:310-14.
9. Visvanathan K, Vang R, Shaw P, et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: A reproducibility study. Am J Surg Pathol 2011;35:1766-75.
10. Powell CB, Chen LM, McLennan J, et al. Risk-reducing salpingo- oophorectomy (RRSO) in BRCA mutation carriers: Experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 2011;21:846-51.
11. Carcangiu ML, Radice P, Manoukian S, et al. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. Int J Gynecol Pathol 2004;23: 35-40. (Pubitemid 38018235)
12. Hirst JE, Gard GB, McIllroy K, et al. High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. Int J Gynecol Cancer 2009;19:826-9.
13. Leunen K, Legius E, Moerman P, et al. Prophylactic salpingooophorectomy in 51 women with familial breast-ovarian cancer: Importance of fallopian tube dysplasia. Int J Gynecol Cancer 2006;16:183-8.
14. Manchanda R, Abdelraheim A, Johnson M, et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG 2011;118:814-24.
15. Shaw PA, Rouzbahman M, Pizer ES, et al. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol 2009;22:1133-8.
16. Vicus D, Shaw PA, Finch A, et al. Risk factors for noninvasive lesions of the fallopian tube in BRCA mutation carriers. Gynecol Oncol 2010;118:295-98.
17. Colgan TJ, Murphy J, Cole DE, et al. Occult carcinoma in prophylactic oophorectomy specimens: Prevalence and association with BRCA germline mutation status. Am J Surg Pathol 2001;25:1283-9. (Pubitemid 32917122)
18. Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 2006;100:58-4. (Pubitemid 41815050)
19. Powell CB, Kenley E, Chen LM, et al. Risk-reducing salpingooophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy. J Clin Oncol 2005;23:127-2. (Pubitemid 41702631)
20. Crum CP, Drapkin R, Miron A, et al. The distal fallopian tube: A new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007;19:3-9. (Pubitemid 46095865)
21. Jarboe EA, Folkins AK, Drapkin R, et al. Tubal and ovarian pathways to pelvic epithelial cancer: A pathological perspective. Histopathology 2008;53:127-38. (Pubitemid 352032762)
22. Tang S, Onuma K, Deb P, et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: A study of 300 consecutive cases. Int J Gynecol Pathol 2012;31:103-10.
23. Semmel DR, Folkins AK, Hirsch MS, et al. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol 2009;22:985-8.
24. Chang PS, Crum CP. The fallopian tube and broad ligament. In: Crum CP, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia, PA: Saunders/Elsevier; 2006:698-701.
25. Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34:1407-16.
26. Rabban JT, Krasik E, Chen LM, et al. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: Implications for defining an optimal specimen dissection protocol. Am J Surg Pathol 2009;33:1878-5.